Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Value-Based Cancer Care

- PMLiVE

New UK leadership roles at WPP Health Practice

Data, insight, and creativity at the heart of offering

- PMLiVE

We are Gold! Porterhouse Medical Group is recognised as an ‘Investor in People’ at the Gold level

Porterhouse Medical Group is delighted to announce that we have been awarded the Investors in People (IIP) accreditation at the Gold level, demonstrating our commitment to realising the potential of...

Porterhouse Medical Group

- PMLiVE

Illumina sets up first ex-US accelerator site in Cambridge

Boost for UK's golden triangle biotech region

- PMLiVE

Kisqali combination follows Verzenio onto Cancer Drugs Fund

Drug must prove its value via managed access route

- PMLiVE

Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance

Targeting largest family of proteins in cell membranes

- PMLiVE

ACPs to lead gene therapies in haemophilia market growth

New therapies to hit existing players

- PMLiVE

FDA starts speedy review of Novartis’ sickle cell antibody

Among several $1bn+ late-stage drugs in company's pipeline

- PMLiVE

Recursion raises $121m for AI-led drug discovery

Funds will fuel in house pipeline and tech

- PMLiVE

AbbVie cures STING fever with Mavupharma acquisition

Joins host of companies pursuing novel mechanism

Bluedog is bursting with new creative and digital talent

Bluedog, a Lucid Group company, welcomes four spellbinding new additions to its team.With a strong background in animation, Rachel Sparks joins Bluedog as a motion designer. Having previously worked in...

Lucid Group Communications Limited

- PMLiVE

Gilead strikes $5.1bn deal to bolster ties with Galapagos

Big boost for Belgian biotech, without a buy-out

- PMLiVE

AbbVie’s Skyrizi gets rapid ‘yes’ from NICE

New fast-track appraisal a boon for companies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links